260 related articles for article (PubMed ID: 11315344)
21. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
Walden PA; Philalithis PE; Joekes AM; Bagshawe KD
Clin Nephrol; 1977 Jul; 8(1):317-20. PubMed ID: 577907
[TBL] [Abstract][Full Text] [Related]
22. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
Tsakonas E; Joseph L; Esdaile JM; Choquette D; Senécal JL; Cividino A; Danoff D; Osterland CK; Yeadon C; Smith CD
Lupus; 1998; 7(2):80-5. PubMed ID: 9541091
[TBL] [Abstract][Full Text] [Related]
23. [Immunosuppressive therapy of systemic lupus erythematosus].
Miescher PA; Lambert PH
Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
[No Abstract] [Full Text] [Related]
24. Letter: Immunosuppressive drugs in lupus nephritis.
Epstein WV; Shearn MA
Ann Intern Med; 1976 Apr; 84(4):492-3. PubMed ID: 1259300
[No Abstract] [Full Text] [Related]
25. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
Appleby P; Webber DG; Bowen JG
Clin Exp Immunol; 1989 Dec; 78(3):449-53. PubMed ID: 2612055
[TBL] [Abstract][Full Text] [Related]
26. Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
Wang SW; Cheng TT
Lupus; 2005; 14(6):483-5. PubMed ID: 16038113
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.
Mahmoud GA; Shahin AA; Zayed HS; Moghazy A; Eissa BM
Lupus; 2018 Aug; 27(9):1562-1569. PubMed ID: 29788810
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Chang HK
J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
[TBL] [Abstract][Full Text] [Related]
29. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
Clément F
Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
[No Abstract] [Full Text] [Related]
30. [Cutaneous involvement in systemic Chagas disease in immunocompromised patient].
Canese A; Di Martino Ortiz B; González Burgos L; Centurión MÉ
Med Clin (Barc); 2012 May; 138(14):e27. PubMed ID: 22093407
[No Abstract] [Full Text] [Related]
31. [Bullous systemic lupus erythematosus].
Bacman D; Ostendorf B; Megahed M; Ruzicka T; Schneider M; Kuhn A
Hautarzt; 2004 Apr; 55(4):392-5. PubMed ID: 15021938
[TBL] [Abstract][Full Text] [Related]
32. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.
Fischer-Betz R; Specker C; Brinks R; Aringer M; Schneider M
Rheumatology (Oxford); 2013 Jun; 52(6):1070-6. PubMed ID: 23382355
[TBL] [Abstract][Full Text] [Related]
33. Lupus activity in pregnancy.
Clowse ME
Rheum Dis Clin North Am; 2007 May; 33(2):237-52, v. PubMed ID: 17499705
[TBL] [Abstract][Full Text] [Related]
34. [Combined immunosuppressive treatment of systemic lupus erythematosus].
Pluzańska A; Dmochowska M; Orlowski Z; Pawlowski J; Krauze-Jaworska H; Krykowski E; Zebrowski A
Pol Arch Med Wewn; 1974 Sep; 52(3):275-81. PubMed ID: 4418141
[No Abstract] [Full Text] [Related]
35. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
36. Mucormycosis complications in systemic lupus erythematosus.
Arce-Salinas CA; Pérez-Silva E
Lupus; 2010 Jul; 19(8):985-8. PubMed ID: 20064915
[TBL] [Abstract][Full Text] [Related]
37. Predictors of flares and long-term outcome of systemic lupus erythematosus during combined treatment with azathioprine and low-dose prednisolone.
Oelzner P; Abendroth K; Hein G; Stein G
Rheumatol Int; 1996; 16(4):133-9. PubMed ID: 8961376
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
39. Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome.
Benseler SM; Bargman JM; Feldman BM; Tyrrell PN; Harvey E; Hebert D; Silverman ED
Rheumatology (Oxford); 2009 Feb; 48(2):176-82. PubMed ID: 19141574
[TBL] [Abstract][Full Text] [Related]
40. The clinical characteristics of lupus related protein-losing enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital.
Law ST; Ma KM; Li KK
Lupus; 2012 Jul; 21(8):840-7. PubMed ID: 22343095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
